Today: 9 June 2026
DBS stock pulls back from S$60 record as traders focus on Feb 9 earnings
30 January 2026
2 mins read

DBS stock pulls back from S$60 record as traders focus on Feb 9 earnings

Singapore, Jan 30, 2026, 14:42 SGT — Regular session

  • DBS shares dipped in afternoon trading, retreating from their S$60 peak hit just a day before
  • Fed’s pause this week puts rate outlook back under the spotlight
  • DBS is set to report results on Feb 9, with investors watching closely for updates on margins and dividend guidance

Shares of DBS Group Holdings Ltd slipped 0.7% to S$59.38 by 2:22 p.m. local time on Friday, retreating from a near 52-week peak of S$60. The stock fluctuated between S$59.19 and S$59.65 during the session, after closing at S$59.79 previously.

The slide matters because DBS is already priced for perfection. Singapore bank stocks have been driven to peak levels, and now investors are looking for upcoming earnings and rate cues to back up the optimism.

Rate expectations are key here. Banks rely on the net interest margin — the difference between earnings on loans and costs paid to depositors — and that margin shrinks if rates drop quicker than lenders adjust their pricing.

The U.S. Federal Reserve kept its benchmark rate steady at 3.5% to 3.75% on Wednesday, signaling it will assess incoming data and risks before deciding on any future hikes.

Interest-rate futures now price the next Fed cut for June, even as investors argue over how much easing remains in the cycle, Reuters reported.

DBS hit a new high, opening at S$60 on Thursday, The Edge Singapore reported. JPMorgan’s Harsh Wardhan Modi and Daniel Andrew Tan said in a Nov. 28 note that the bank “should be part of global portfolios,” setting a S$70 price target for December 2026, the report added. Bloomberg estimates cited by the publication project around S$2.6 billion in profit for Q4, with about S$11.4 billion for the full year. The Edge Singapore

DBS ended Thursday at S$59.79, marking a 0.4% gain, while the Straits Times Index also climbed 0.4% following the Fed’s pause, according to The Business Times. Vishnu Varathan, head of macro research for Asia ex-Japan at Mizuho Securities in Singapore, noted the pause was “universally expected” but added the tone had “a more hawkish edge.” The Business Times

Other local banks showed mixed results on Friday. OCBC held steady at S$21.35, but UOB slipped 0.8% to S$38.36.

DBS is set to release its full-year 2025 results on Feb. 9, with the report scheduled before the market opens, according to a notice on SGXNET.

Investors will scrutinize the numbers for any hint the earnings engine is slowing down: loan growth, fee income from wealth and cards, plus any uptick in credit costs. They’ll also look for signals on dividends and capital returns, especially with the share price hovering near its highs.

There’s a catch to the rally. Should global yields drop sharply, margins could shrink quicker than anticipated. And if bad loans spike unexpectedly, the hit will be tougher, given the high expectations already priced in.

DBS will next face the spotlight on Feb. 9, when it reports its fourth-quarter results. The bank’s schedule also notes its annual meeting on March 31 and first-quarter earnings due April 30.

Stock Market Today

  • BofA Analyst Boosts Nebius (NBIS) Price Target on Growing AI Compute Demand
    June 9, 2026, 11:03 AM EDT. Nebius (NBIS) shares have surged over 160% year-to-date amid rising artificial intelligence (AI) driven demand for cloud computing resources. A top Bank of America (BofA) analyst raised the price target for Nebius, citing strengthening compute demand as a key growth driver. Despite recent market volatility linked to macroeconomic concerns, Nebius's focus on neocloud technology positions it well to capitalize on expanding AI workloads. The analyst's upgrade suggests increased confidence in Nebius's ability to meet future demand and sustain growth momentum in the competitive cloud infrastructure sector.

Latest articles

Smart Logistics Jumps 159% Before Nasdaq Halt

Smart Logistics Jumps 159% Before Nasdaq Halt

9 June 2026
Smart Logistics Global soared 158.75% to $1.33 before a Nasdaq volatility pause, putting the stock above the $1 minimum bid-price needed for compliance after months below the threshold; the company must now close at or above $1 for 10 straight business days to avoid further Nasdaq action, with no new company news driving the surge.
Reddit Shares Pop After Wall Street Sees the Right Ad Signal

Reddit Shares Pop After Wall Street Sees the Right Ad Signal

9 June 2026
Reddit shares surged 6.6% to $182.44 after Cleveland Research and Piper Sandler cited stronger ad demand and raised revenue forecasts, with Cleveland noting 45% of advertisers beat ROI targets in Q2 and Reddit taking ad share from rivals, but risks remain around user growth, AI search traffic, and high valuation.
Autozi Shares Jump 400%, Filing Flags Risks for AZI

Autozi Shares Jump 400%, Filing Flags Risks for AZI

9 June 2026
Autozi Internet Technology shares soared over 400% to $5.69 in early Nasdaq trading after a 10-for-1 share consolidation slashed its share count to about 4.49 million, but the surge contrasts with a 63.1% revenue drop, 82.5% plunge in gross profit, and widened net loss, with the company warning of “substantial doubt” about its ability to continue as a going concern.
Redwire Shares Slip After $500 Million Stock Offering Filed

Redwire Shares Slip After $500 Million Stock Offering Filed

9 June 2026
Redwire Corp shares plunged 6.5% to $17.37 after launching a $500 million at-the-market stock program, raising dilution risks for investors as the company seeks flexible funding despite recent record backlog and strong revenue growth; the drop contrasted with gains at other space stocks, highlighting investor concern over potential share issuance.
Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

Nuvalent Trades Close to $124 After GSK’s $10.6 Billion Offer

9 June 2026
Nuvalent shares soared 38.9% to $122.93, just below GSK’s $124-a-share cash offer after the $10.6 billion buyout was announced, as investors bet on the deal closing with Nuvalent’s two lead lung-cancer drugs already under FDA review and a 40% premium to the last closing price driving the morning’s merger-arb trade.
Accenture stock slides 3% as new share award pool wins approval — what investors watch next
Previous Story

Accenture stock slides 3% as new share award pool wins approval — what investors watch next

GSK share price dips in London as Exdensur rollout and Feb 4 results loom
Next Story

GSK share price dips in London as Exdensur rollout and Feb 4 results loom

Go toTop